MA28861B1 - STABLE LIQUID FORMULATIONS OF PLASMIDIC DNA - Google Patents

STABLE LIQUID FORMULATIONS OF PLASMIDIC DNA

Info

Publication number
MA28861B1
MA28861B1 MA29755A MA29755A MA28861B1 MA 28861 B1 MA28861 B1 MA 28861B1 MA 29755 A MA29755 A MA 29755A MA 29755 A MA29755 A MA 29755A MA 28861 B1 MA28861 B1 MA 28861B1
Authority
MA
Morocco
Prior art keywords
liquid formulations
stable liquid
plasmidic dna
plasmidic
dna
Prior art date
Application number
MA29755A
Other languages
French (fr)
Inventor
Francis Blanche
Michel Couder
Nicolas Maestrali
Thierry Guillemin
David Gaillac
Original Assignee
Centelion
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP2004/011437 external-priority patent/WO2005026331A2/en
Priority claimed from PCT/EP2005/005213 external-priority patent/WO2005100542A1/en
Application filed by Centelion filed Critical Centelion
Publication of MA28861B1 publication Critical patent/MA28861B1/en

Links

MA29755A 2004-09-17 2007-03-14 STABLE LIQUID FORMULATIONS OF PLASMIDIC DNA MA28861B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/EP2004/011437 WO2005026331A2 (en) 2003-09-17 2004-09-17 Method of preparation of pharmaceutically grade plasmid dna
PCT/EP2005/005213 WO2005100542A1 (en) 2004-04-19 2005-04-19 Method for purifying plasmid dna

Publications (1)

Publication Number Publication Date
MA28861B1 true MA28861B1 (en) 2007-09-03

Family

ID=40680521

Family Applications (1)

Application Number Title Priority Date Filing Date
MA29755A MA28861B1 (en) 2004-09-17 2007-03-14 STABLE LIQUID FORMULATIONS OF PLASMIDIC DNA

Country Status (2)

Country Link
MA (1) MA28861B1 (en)
ZA (1) ZA200702211B (en)

Also Published As

Publication number Publication date
ZA200702211B (en) 2008-09-25

Similar Documents

Publication Publication Date Title
IL183252A0 (en) Solid formulations of liquid biologically active agents
IL181753A0 (en) Stable liquid formulations of plasmid dna
MA29109B1 (en) NOVEL 2-CYANO-3 (HALOGENO) ALCOXY-BENZENESULFONAMIDE COMPOUNDS FOR COMBATTING ANIMAL HARMFUL ORGANISMS
FR16C1012I2 (en) THERAPEUTIC USE OF ANTI-CS1 ANTIBODIES
MA29014B1 (en) ANTIBODY FORMULATIONS
NO20053987L (en) Liquid pharmaceutical palonosetron formulations
DK1747290T3 (en) Use of whole blood in PCR reactions
IL158802A0 (en) Stable liquid formulations of antibodies
DE60329592D1 (en) BUBBLE LIQUID NICOTINE COMPOSITION FOR PULMONARY ADMINISTRATION
ATE497696T1 (en) LIQUID PESTICIDE COMPOSITIONS
ATE542422T1 (en) LIQUID SULFONYL UREA HERBICIDE FORMULATIONS
WO2007025988A3 (en) Liquid formulations of pegylated growth hormone
MA29030B1 (en) 2-ALCOXY-3,4,5-TRIHYDROXY-ALKYLAMIDES, PREPARATION THEREOF, COMPOSITIONS CONTAINING SAME AND USE THEREOF
FR2873585B1 (en) NEW GALENIC FORMULATIONS OF ACTIVE PRINCIPLES
FR2871145B1 (en) DISTRIBUTOR OF APPLICATORS
NO20054662D0 (en) Pharmaceutical composition comprising 5-methyl-2-2 '- (chloro-6'-fluoroaniline) phenylacetic acid
DE602004013557D1 (en) LIQUID FORMULATIONS OF THE TUMORNEKROSE FRACTURE BINDING PROTEIN TBP-1
DE602004009573D1 (en) PREPARATION OF 5-METHYL-DIHYDROFURAN-2-ON FROM LEVULINIC ACID IN SUPERCRITICAL MEDIA
MA28861B1 (en) STABLE LIQUID FORMULATIONS OF PLASMIDIC DNA
FR2858771B1 (en) ASSOCIATION OF ACTIVE AGENTS EXTRACTED FROM ALGAE AND COSMETIC COMPOSITIONS COMPRISING SAID ASSOCIATION
FR2874325B1 (en) PHARMACEUTICAL COMPOSITION IN THE FORM OF A GASTRIC RESISTANCE COMPRESSOR CONTAINING ALFUZOSIN
DE602004010172D1 (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF KIDNEY FUNCTIONAL DISORDERS
FR2867980B1 (en) USE OF MASTICADIENONIC ACID AS BETA DNA POLYMERASE INHIBITOR
FR2873918B1 (en) USE OF A TRITICUM MONOCOCCUM EXTRACT AS AN ACTIVE INGREDIENT IN A COSMETIC AND / OR PHARMACEUTICAL COMPOSITION
FR2872511B1 (en) NOVEL INHIBITORS OF ANGIOGENESIS AND THEIR PHARMACEUTICAL AND COSMETIC USE